title: Identification of late-stage glycosylation steps in the biosynthetic pathway of the anthracycline nogalamycin.
abstract: Nogalamycin is an anthracycline antibiotic that has been shown to exhibit significant cytotoxicity. Its biological activity requires two deoxysugar moieties: nogalose and nogalamine, which are attached at C7 and C1, respectively, of the aromatic polyketide aglycone. Curiously, the aminosugar nogalamine is also connected through a C-C bond between C2 and C5''. Despite extensive molecular genetic characterization of early biosynthetic steps, nogalamycin glycosylation has not been investigated in detail. Here we show that expression of the majority of the gene cluster in Streptomyces albus led to accumulation of three new anthracyclines, which unexpectedly included nogalamycin derivatives in which nogalamine was replaced either by rhodosamine with the C-C bond intact (nogalamycin R) or by 2-deoxyfucose without the C-C bond (nogalamycin F). In addition, a monoglycosylated intermediate-3',4'-demethoxynogalose-1-hydroxynogalamycinone-was isolated. Importantly, when the remaining biosynthetic genes were introduced into the heterologous host by using a two-plasmid system, nogalamycin could be isolated from the cultures, thus indicating that the whole gene cluster had been identified. We further show that one of the three glycosyltransferases (GTs) residing in the cluster-snogZ-appears to be redundant, whereas gene inactivation experiments revealed that snogE and snogD act as nogalose and nogalamine transferases, respectively. The substrate specificity of the nogalamine transferase SnogD was demonstrated in vitro: the enzyme was able to remove 2deoxyfucose from nogalamycin F. All of the new compounds were found to inhibit human topoisomerase I in activity measurements, whereas only nogalamycin R showed minor activity against topoisomerase II.
authors: Department of Biochemistry and Food Chemistry, University of Turku, Turku, Finland.
authors: Vilja
authors: V
authors: Siitonen
authors: Magnus
authors: M
authors: Claesson
authors: Pekka
authors: P
authors: Patrikainen
authors: Maria
authors: M
authors: Aromaa
authors: Pekka
authors: P
authors: Mäntsälä
authors: Gunter
authors: G
authors: Schneider
authors: Mikko
authors: M
authors: Metsä-Ketelä
mesh_terms: D053898:Biosynthetic Pathways / Q000235:genetics*; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D006031:Glycosylation; D016695:Glycosyltransferases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D009621:Nogalamycin / Q000031:analogs & derivatives / Q000096:biosynthesis* / Q000494:pharmacology; D013302:Streptomyces / Q000201:enzymology / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship
chemical_list: D004791:Enzyme Inhibitors; D016695:Glycosyltransferases; D004264:DNA Topoisomerases, Type I; D009621:Nogalamycin